- 2022/02/07
- Homepage release
-
Creating a new drug discovery platform, connecting Japan and Asia
EPS Innovative Medicine interfaces between discovery research of new seeds by academia /bio-venture companies and markets by facilitating early launch of potential drugs.
SWIPESCROLL
Diverse pipeline
EPS Innovative Medicine is engaged in discovery and development of a set of various drug candidates in pipeline to be launched into Asian and other overseas markets.
Japan-based,
globally oriented company
EPS Innovative Medicine is the first drug discovery company established to mark the 30th anniversary of EPS, a leading Japan-based contract research organization (CRO).